Vandana Singh
·
August 22, 2025
Benzinga
Biohaven shares rise as FDA removes advisory committee meeting for troriluzole in spinocerebellar ataxia, with decision expected in late 2025.
read more
November 7, 2025
September 5, 2025
August 28, 2025
Bloomberg
September 4, 2025
Fortune